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Long-Term Outcomes After Angioplasty or Stenting for In-Stent Restenosis
Alfonso and colleagues report on the three- to five-year outcomes of subjects within-stent restenosis (ISR)whowere randomized to either balloon angioplasty (BA)
or repeat stenting as part of the Restenosis Intrastent: Balloon angioplasty versus
elective Stenting (RIBS) study. During long-term follow-up of the 450 participants,
similar percentages of patients died, sufferedmyocardial infarctions, required coronary
surgery, and/or underwent repeat coronary interventions. The event-free survival was
statistically equivalent between the groups (63%vs. 69%).Vessels3mm indiameter
had better outcomes with stenting than BA, but otherwise, subgroup analysis did not
reveal any significantdifferences. In conclusion, subjectswith ahistoryof ISRhavehigh
rates of adverse cardiac events regardless of the treatment strategy; stenting improves
outcomes only for vessels3 mm. See page 756.
Interventional Cardiology
Rescue Stenting for Renal Artery Angioplasty
The utility of using stents for renal artery angioplasty has been questioned. TheASPIRE-2 study enrolled subjects after renal artery angioplasty if there was a
residual stenosis, a translesional pressure gradient, or a visible dissection. All of these
failed angioplasties were then stented. Duplex renal ultrasonography was performed at
9months and clinical follow-up at 24months. Stent placement was deemed successful
in 80% of lesions; the nine-month binary restenosis rate was 17%. There was an
approximately 20-point decline in systolic blood pressure associated with the proce-
dure that was maintained over 24 months. The 24-month cumulative rate of major
adverse events was 20%, with most events being target lesion revascularization. This
study suggests that renal stenting is safe and initially effective after a failed angioplasty
attempt, but restenosis is common. See page 776.
Page 803
Acute Coronary Syndrome
Ox-LDL Stimulates Inflammatory Response Through NF-kB Pathways
Cominacini and colleagues examined the interactionbetweenoxidized low-densitylipoprotein (ox-LDL) and nuclear factor-kB (NF-kB) activation with the aim of
understanding the transition from stable to unstable angina. NF-kB is known to
activate several inflammatory pathways in responses to various stimulants such as
cytokines and has been found in coronary plaques. For this study, blood samples were
collected from control subjects, subjects with stable angina, and subjects with unstable
angina. The levels of both ox-LDL and NF-kB were lowest in control subjects and
increased progressively with stable and then unstable angina. In addition, the sera from
subjects with unstable angina can increase NF-kB expression from cultured cells; this
activation appears to be from ox-LDL through the lectin-like ox-LDL receptor-1
which is present on monocytes. This suggests that increased levels of ox-LDL lead to
increased levels of NF-kB, which in turn stimulates inflammatory pathways, and helps
to explain the diffuse plaque inflammation often seen during acute coronary syn-
dromes. See page 799. See figure.
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Prognostic Markers in CAD
EBCT Improves Cardiac Risk Prediction
While electron beam computed tomography (EBCT) screening has proveneffective in high-risk individuals, its efficacy in the general population remains
controversial. The Prospective Army Coronary Calcium (PACC) project enrolled
2,000 asymptomatic, presumably healthy men and women age 40 to 50 years. All
subjects received anEBCTand a comprehensive assessment of their cardiovascular risk
factors including family history, lipid profile, body mass index, and presence of
metabolic syndrome. Subjects were then followed for a median of three years. The
prevalence of any detectable coronary artery calcium (CAC) was 22.4% in men and
7.9% in women. The rate of cardiac events in subjects with positive CAC was 2%
versus 0.16%in subjectswithnoCAC. In amodel controlling for theFraminghamrisk
score, the presence of CAC was associated with an 11.8-fold increased risk. A cost-
effectiveness analysis suggests that CAC screening may be reasonably priced in this
population if it increases the use of effective primary preventionmodalities.See page
807. See figure.
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Diabetes and
Cardiovascular Disease
Diabetes Associated With Impaired VEGF Signaling
Diabetics have impaired collateral formation. Vascular endothelial growth factor(VEGF) is an important component of neoangiogenesis and collateral forma-
tion; animal studies suggest that diabetesmay result in impairedVEGF signaling. Sasso
and colleagues collected myocardial biopsy specimens from subjects with and without
diabetes undergoing bypass surgery and normal subjects. They report that diabetics
actually have higher VEGF concentrations, but that they have reduced numbers of
receptors for VEGF. This leads to reduced phosphorylation of Akt and endothelial
nitric oxide both of which are important in the formation of new collateral vessels and
helps to explain the reduced collateral formation with diabetes. It also suggests that
therapies to stimulate VEGF expression are unlikely to result in significant collateral
formation in diabetic subjects, unless the number of receptors can also be increased.
See page 827. See figure.
Cardiac Surgery
Meta-Analysis of Off-Pump Coronary Artery Surgery
Off-pump coronary bypass surgery (OPCAB) abrogates the need for cardiopul-monary bypass and aortic cross-clamping, but requires that the coronary anas-
tomoses be performed on a beating heart. The net effect on morbidity and mortality
remains controversial. Wijeysundera and colleagues report the result of a large meta-
analysis that includes more than 3,000 patients enrolled in randomized clinical trials
(RCTs) and almost 300,000 from observational studies. In the observational studies,
OPCAB was associated with significant reductions in stroke, 30-day mortality, and
myocardial infarction. In theRCTs these differences,while still favoringOPCAB,were
statistically non-significant. Long-term mortality was similar among both techniques,
but trends suggest that OPCAB may be associated with more frequent need for
revascularization. See page 872.
(continued) A-40Hypertrophic Cardiomyopathy
Paroxetine Improves Inappropriate BP Reflexes in HCM
Hypertrophic cardiomyopathy (HCM) can cause exertional syncope, in subjectswith and without outflow tract obstruction. The etiology in nonobstructive
HCM is unclear, but one-third of these subjects do not appropriately increase their
blood pressure (BP) during exercise. Thaman and colleagues studied 21 subjects whose
BP did not rise by at least 25 mm Hg during exercise. They then assessed forearm
vasodilator responses to lower body negative pressure (ventricular unloading) and
responses to three medications typically used for vasovagal syncope: propranolol,
clonidine, and paroxetine. Approximately one-half of the subjects inappropriately
vasodilated during lower body negative pressure; interestingly this response was abro-
gated by paroxetinewhich also increased the proportion of subjectswho raised their BP
during exercise. Paroxetine appeared to be more effective than either propranolol or
clonidine in correcting these abnormal responses, though the mechanism is unclear.
See page 883.
